Table 1. Distribution of actual viral load values of each testing method.
Total (n = 757) n (column %) |
Before ART (n = 79) n (row %) |
On ART (n = 678) n (row %) |
||
---|---|---|---|---|
Plasma VL copies/ml | ||||
VL<20 | 613 (81.0%) | 0 | 613 (100.0%) | |
20≤VL<1000 | 63 (8.3%) | 2 (3.2%) | 61 (96.8%) | |
1000≤VL<5000 | 2 (0.3%) | 1 (50.0%) | 1 (50.0%) | |
≥5000 | 79 (10.4%) | 76 (96.2%) | 3 (3.8%) | |
DBS-SPEX VL copies/ml | ||||
VL<400 | 344 (45.4%) | 2 (0.6%) | 342 (99.4%) | |
400≤VL<1000 | 159 (21.0%) | 0 | 159 (100.0%) | |
1000≤VL<5000 | 167 (22.1%) | 6 (3.6%) | 161 (96.4%) | |
≥5000 | 87 (11.5%) | 71 (81.6%) | 16 (18.4%) | |
DBS-FVE VL copies/ml | ||||
VL<400 | 667 (88.1%) | 4 (0.6%) | 663 (99.4%) | |
400≤VL<1000 | 21 (2.8%) | 10 (47.6%) | 11 (52.4%) | |
1000≤VL<5000 | 27 (3.6%) | 24 (88.9%) | 3 (11.1%) | |
≥5000 | 42 (5.5%) | 41 (97.6%) | 1 (2.4%) |